The goal: Increase natural dopamine production and up-regulation of Dopamine Receptors.
The hypothesis: Intake of a Dopamine Antagonist -Metoclopramide- in a very small dose (one tenth of the usual dose) will cause an increased endogenous production of dopamine and up-regulation of the D-Receptors as a response to the blockage for a short period of time ( substance half life:4-6 hours)
Based on: The principle upon which Low Dose Naltrexone works.
Possible applications: Low motivation, ADHD, Asthenia, Depression, Anxiety, Parkinson's like symptoms, any other condition associated with low dopaminergic activity.
Dose: 1mg
1/10th of the normal dose of 10 mg
I am aware that this approach is completely counter-intuitive, for it is stated that:
"Contraindications: "Metoclopramide is contraindicated in pheochromocytoma. It should be used with caution in Parkinson's disease since, as a dopamine antagonist, it may worsen symptoms. Long-term use should be avoided in patients with clinical depression as it may worsen mental state.[3] Also contraindicated with a suspected bowel obstruction.[1]
Patients with a history of ADHD, Restless legs syndrome, Hyperprolactinaemia, and Parkinson's disease should be closely monitored when using dopamine antagonists for treatment of emesis. Patients who take antipsychotics are recommended not to take metoclopramide"
However, the very same could be said for the use of Naltrexone in conditions where b-endorphins are lacking, and yet, this somewhat paradoxical mechanism of action seems to work in favor of natural increased production.
Anyone care to add before I try this non-orthodox approach?